XML 60 R43.htm IDEA: XBRL DOCUMENT v3.19.2
Investment in Silver Creek - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
May 07, 2019
May 31, 2019
Jun. 30, 2019
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Sep. 30, 2017
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Effects Of Changes Net [Line Items]              
Equity method investment           $ 7,428  
Proceeds from maturities and sales of marketable securities       $ 48,500 $ 11,050    
Equity method investment realized gain loss on sale     $ 1,400 $ 1,400      
Silver Creek Pharmaceuticals, Inc. [Member]              
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Effects Of Changes Net [Line Items]              
Equity method investment $ 6,400            
Proceeds from maturities and sales of marketable securities $ 7,800 $ 7,800          
Silver Creek Pharmaceuticals, Inc. [Member] | Maximum [Member]              
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Effects Of Changes Net [Line Items]              
Ownership interest percentage held by parent             50.00%